Medroxyprogesterone Acetate anticorps
Cet anticorps anti-Medroxyprogesterone Acetate est un anticorps Mouton Polyclonal détectant Medroxyprogesterone Acetate dans EIA. Adapté pour .
N° du produit ABIN487732
Aperçu rapide pour Medroxyprogesterone Acetate anticorps (ABIN487732)
Antigène
Medroxyprogesterone Acetate
Reactivité
Veuillez nous consulter SVP
Hôte
Mouton
Clonalité
Polyclonal
Conjugué
Cet anticorp Medroxyprogesterone Acetate est non-conjugé
Application
Enzyme Immunoassay (EIA)
-
-
Purification
- Ig Fraction
-
Immunogène
- Medroxyprogesterone acetate (3)-BTG
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
ELISA: 0.1 μg/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 9.70mg/mL (U.V. abs at 280nm)
-
Buffer
- 20 mM Phosphate, 150 mM Sodium Chloride, pH 7.2 containing 0.09 % Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- -20 °C
-
-
- Medroxyprogesterone Acetate
-
Classe de substances
- Chemical
-
Sujet
- MPA (also known as depo provera) is a highly potent progestational steroid that has been used worldwide as a contraceptive. There has been a concern about the possibility of an increased risk of breast cancer associated with its use. On the other hand, MPA when employed at high doses (>0.5 - 1.0g / day i.m.) can produce objective remission with improved survival in about 30?% of postmenopausal women with advanced breast cancer resistant to cytotoxic drugs and endocrine therapies. Early results suggest that the response rate can be increased in patients with estrogen and / or progesterone positive receptors.Synonyms: MPA, Medroxy Progesterone Acetate, depo provera
Antigène
-
Vous êtes ici:
